NCT00744185.

Methods	Parallel‐group, phase II and III, RCT
Participants	Up to 4 months of age, male and female, 1 or more haemangiomas sized more than 1 cm in diameter, social insurance, infant not threatened for vital or functional structure and for which no treatment would be proposed Age: up to 4 months Sex: all Country: France
Interventions	Propranolol (3 mg/kg for 15 days then 4 mg/kg for 15 days) versus placebo (for 30 days)
Outcomes	Primary outcome: Proportion of haemangioma thickness variation, measured using ultrasonography from the basal state after 1 month Secondary outcomes: Proportion of haemangioma size variation, measured clinically and with photography from the basal state after 1 month Observance
Notes	This study has been terminated. (Study halted prematurely due to difficulties in recruitment of participants.)